Association study between BDNF C-281A polymorphism and paranoid schizophrenia in Polish population

Journal of Molecular Neuroscience

Volumn 46, Issue 1, 2012, Pages 217-222

  Suchanek, Renata ^a   Owczarek, Aleksander ^a   Kowalski, Jan ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

BDNF; Haplotype; PANSS; Paranoid schizophrenia; Polymorphism C 281A; Suicide

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARANOID SCHIZOPHRENIA; PATHOGENESIS; POLAND; POSITIVE AND NEGATIVE SYNDROME SCALE; SUICIDAL BEHAVIOR; CASE CONTROL STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM;

ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SCHIZOPHRENIA, PARANOID; SEX FACTORS;

EID: 84858846969     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-011-9582-7     Document Type: Article

References (29)

1. Belcher SM, Zsarnovszky A (2001) Estrogenic actions in the brain: estrogen, phytoestrogens, and rapid intracellular signaling mechanisms. J Pharmacol Exp Ther 299:408-414 (Pubitemid 32979650)
2. Bradley AJ, Dinan TG (2010) A systematic review of hypothalamic- pituitary-adrenal axis function in schizophrenia: implications for mortality. J Psychopharmacol 24(4 Suppl):91-118
3. Chang HA, Lu RB, Shy MJ, Chang CC, Lee MS, Huang SY (2009) Brain-derived neurotrophic factor Val66Met polymorphism: association with psychopathological symptoms of schizophrenia? J Neuropsychiatry Clin Neurosci 21:30-37
4. Chao MV, Rajagopal R, Lee FS (2006) Neurotrophin signalling in health and disease. Clin Sci (Lond) 110(2):167-173 (Pubitemid 43241478)
5. Chen DC, Wang J, Wang B et al (2009) Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes. Psychopharmacology (Berl) 207:375-380
6. Craddock N, O'Donovan MC, Owen MJ (2005) The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J Med Genet 42:193-204 (Pubitemid 40380298)
7. Dell'osso L, Carmassi C, Del Debbio A, Dell'osso MC, Bianchi C, da Pozzo E et al (2009) Brain-derived neurotrophic factor plasma levels in patients suffering from post-traumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry 33(5):899-902
8. Dwivedi Y (2010) Brain-derived neurotrophic factor and suicide pathogenesis. Ann Med 42:87-96
9. Fatemi SH, Folsom TD (2009) The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull 35(3):528-548
10. Guillin O, Demily C, Thibaut F (2007) Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine. Int Rev Neurobiol 78:377-395
11. Hashimoto T, Bergen SE, Nguyen QL, Xu B, Monteggia LM, Pierri JN et al (2005) Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J Neurosci 25(2):372-383 (Pubitemid 40105607)
12. Huang TL, Lee CT (2006) Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients. J Psychiatr Res 40(7):664-668
13. Issa G, Wilson C, Terry AV Jr, Pillai A (2010) An inverse relationship between cortisol and BDNF levels in schizophrenia: data from human postmortem and animal studies. Neurobiol Dis 39 (3):327-333
14. Jiang X, Xu K, Hoberman J, Tian F, Marko AJ, Waheed JF et al (2005) BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 30(7):1353-1361 (Pubitemid 40848089)
15. Kirov G, O'Donovan MC, Owen MJ (2005) Finding schizophrenia genes. J Clin Invest 115:1440-1448 (Pubitemid 40814648)
16. Kumamaru E, Numakawa T, Adachi N, Yagasaki Y, Izumi A, Niyaz M et al (2008) Glucocorticoid prevents brain-derived neurotrophic factor-mediated maturation of synaptic function in developing hippocampal neurons through reduction in the activity of mitogen-activated protein kinase. Mol Endocrinol 22(3):546-558 (Pubitemid 351397784)
17. Kunugi H, Hori H, Adachi N, Numakawa T (2010) Interface between hypothalamic-pituitary-adrenal axis and brain-derived neurotrophic factor in depression. Psychiatry Clin Neurosci 64:447-459
18. Luellen BA, Bianco LE, Schneider LM, Andrews AM (2007) Reduced brain-derived neurotrophic factor is associated with a loss of serotonergic innervation in the hippocampus of aging mice. Genes Brain Behav 6:482-490 (Pubitemid 47024961)
19. Müller MJ (2007) Gender-specific associations of depression with positive and negative symptoms in acute schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 31(5):1095-1100
20. Neves-Pereira M, Cheung JK, Pasdar A, Zhang F, Breen G, Yates P et al (2005) BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 10(2):208-212 (Pubitemid 40188515)
21. Numakawa T, Kumamaru E, Adachi N, Yagasaki Y, Izumi A, Kunugi H (2009) Glucocorticoid receptor interaction with TrkB promotes BDNF-triggered PLC-gamma signaling for glutamate release via a glutamate transporter. Proc Natl Acad Sci USA 106(2):647-652
22. Schumacher J, Jamra RA, Becker T, Ohlraun S, Klopp N, Binder EB et al (2005) Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry 58(4):307-314 (Pubitemid 41133624)
23. Shalev I, Lerer E, Israel S, Uzefovsky F, Gritsenko I, Mankuta D et al (2009) BDNF Val66Met polymorphism is associated with HPA axis reactivity to psychological stress characterized by genotype and gender interactions. Psychoneuroendocrinology 34(3):382-388
24. Sohrabji F, Lewis DK (2006) Estrogen-BDNF interactions: implications for neurodegenerative diseases. Front Neuroendocrinol 27(4):404-414 (Pubitemid 44738016)
25. Suchanek R, Owczarek A, Kowalczyk M, Kucia K, Kowalski J (2011) Association between C-281A and Val66met functional polymorphisms of BDNF gene and risk of recurrent major depressive disorder in Polish population. J Mol Neurosci 43(3):524-530
26. Tost H, Alam T, Meyer-Lindenberg A (2010) Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes. Neurosci Biobehav Rev 34:689-700
27. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ (2006) Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9(4):519-525
28. Weickert CS, Hyde TM, Lipska BK, Herman MM, Weinberger DR, Kleinman JE (2003) Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry 8(6):592-610 (Pubitemid 36898018)
29. Zhou DH, Yan QZ, Yan XM, Li CB, Fang H, Zheng YL et al (2010) The study of BDNF Val66Met polymorphism in Chinese schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 34(6):930-933